ArticleJournal for immunotherapy of cancer2025

Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8

Wonjun Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.